SYK · Stryker Corp
Market Cap
$118.14B
Shares
383.57M
SYK metrics
94 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$303.13
Market cap
$118.14B
Price action
19 metricsPrice change (1W)
-4.4%
Price change (30D)
-8.7%
Price change (3M)
+2.3%
Price change (6M)
-16.9%
Price change (YTD)
-12.4%
Price change (1Y)
-20.7%
Trailing year
Price change (5Y)
+11.3%
52-week high
$394.34
52-week low
$282.58
Change from 52-week high
-21.9%
Change from 52-week low
+9.0%
Annualized volatility
28.1%
Beta
0.2
RSI (14D)
36.4
Price vs SMA 50
-6.4%
Price vs SMA 200
-9.1%
Avg volume (3M)
2.44M
Relative volume
1.1
Average dollar volume
$792.47M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
383.57M
Valuation
12 metricsP / E (TTM)
31.9
Trailing earnings · reciprocal yield 3.1%
PEG ratio
0.7
EV / revenue
5.0×
reciprocal yield 19.9%
EV / EBITDA
18.1×
reciprocal yield 5.5%
EV / EBIT
23.4×
reciprocal yield 4.3%
P / sales
4.6×
reciprocal yield 21.9%
P / book
4.9
reciprocal yield 20.3%
FCF yield
4.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
25.1
reciprocal yield 4.0%
P / operating cash flow
21.4
reciprocal yield 4.7%
Earnings yield
3.2%
Historical valuation
8 metricsP / E historical average (3Y)
41.8×
reciprocal yield 2.4%
P / E historical average (5Y)
42.5×
reciprocal yield 2.4%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
1.1%
Trailing 12 months
Payout ratio
35.3%
Shareholder yield
—
Dividend / share (TTM)
$3.48
Dividend growth YoY
+4.8%
Dividend growth streak
5
Last ex-dividend
2026-06-30
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-30
Profitability
9 metricsGross margin
65.0%
Operating margin
21.4%
Trailing 12 months
Net margin
14.4%
Gross profit (TTM)
$16.79B
Operating profit (TTM)
$5.53B
Net income (TTM)
$3.73B
Trailing 12 months
Diluted EPS (TTM)
$9.65
FCF margin
18.2%
Effective tax rate
27.6%
Growth
11 metricsRevenue growth YoY
+9.4%
Year over year
Net income growth YoY
+44.3%
Revenue (TTM)
$25.84B
Trailing 12 months
EPS growth YoY
+44.1%
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.8%
Revenue CAGR (5Y)
+11.8%
EPS CAGR (3Y)
+10.8%
EPS CAGR (5Y)
+14.9%
FCF CAGR (3Y)
+28.1%
FCF CAGR (5Y)
+9.0%
Quality
14 metricsReturn on equity
15.5%
Return on assets
7.8%
Debt / equity
0.6
Current ratio
2.2
EBITDA (TTM)
$7.16B
Free cash flow (TTM)
$4.70B
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
1.6
Return on invested capital
11.3%
Trailing 12 months
Net cash
−$11.55B
Latest balance sheet
Cash & equivalents
$3.39B
Total assets
$47.93B
Total debt
$14.94B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$5.53B
Capital expenditures (TTM)
$823.00M
R&D (TTM)
$1.66B
SG&A (TTM)
$8.78B
Stock compensation (TTM)
$251.00M
R&D / revenue
6.4%
Stock compensation / revenue
1.0%
Ownership (13F)
3 metrics13F filers
2,269
13F filer change QoQ
-46
Institutional ownership
81.0%
Short interest
3 metricsShort interest
1.8%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
38 / 100
Insider activity
2 metricsNet insider buying (90D)
−$118.20M
Insider-sentiment score
13 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
310764
CUSIP
863667101
13F (30d)
1096 filings
1037 filers
Visit website
Investor relations